In Australia, Microba said clinical testing began in April 2023 with innovator clinicians and has progressed into early adopter uptake. In the UK, management said clinical testing began in May 2025 and remains in the innovator phase. Sales performance: Australia sets another record; supplements transition continuesIn Australia, Microba said it delivered another record quarter for Microbiome Explorer (previously MetaExplore), with Q1 sales of 4,360 tests, up 90% year-on-year. Microba also said MetaPanel adoption in Australia remained steady, reiterating that MetaPanel is not a primary growth focus at present. About Microba Life Sciences (ASX:MAP)Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore.